Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Efficacy of Nonmyeloablative Hematopoietic Cell Transplant (HCT) in Secondary Myelodysplastic Syndrome (MDS) and Its Impact on the Primary Disease.

F. Kerbauy, M. Maris, B. Storer, D. Maloney, D. Niederwieser, E. Agura, M. Pulsipher, T. Chauncey, R. Maziarz, S. Forman, A. Langston, J. Wade, B. Scott, J. Deeg, R. Storb, B. M. Sandmaier

Blood (2005) 106 (11): 792.

https://doi.org/10.1182/blood.V106.11.792.792

Published: 2005

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes.

Frederic Baron, R. Storb, B. Storer, D. Maloney, M. Maris, D. Niederwieser, J. Shizuru, T. Chauncey, B. Bruno, S. Forman, P. McSweeney, R. Maziarz, M. Pulsipher, E. Agura, M. Sorror, J. Wade, B. Sandmaier

Blood (2005) 106 (11): 1143.

https://doi.org/10.1182/blood.V106.11.1143.1143

Published: 2005

Journal Articles

Diagnostic Criteria for Hematopoietic Stem Cell Transplantation-Associated Microangiopathy (TAM): Results of a Consensus Process by an International Working Group.

Tapani Ruutu, G. Barosi, R. J. Benjamin, R. E. Clark, J. N. George, A. Gratwohl, E. Holler, M. Iacobelli, K. Kentouche, B. Lämmle, J. L. Moake, P. Richardson, G. Socié, Z. Zeigler, D. Niederwieser, T. Barbui

Blood (2005) 106 (11): 400.

https://doi.org/10.1182/blood.V106.11.400.400

Published: 2005

Journal Articles

Outcome of Patients with Myelodysplastic Syndromes (MDS) Undergoing Allogeneic Myeloablative Transplantation: A Retrospective Analysis Comparing HLA Matched Unrelated Donor Bone Marrow Transplantation (BMT) to HLA Identical Sibling SCT. A Retrospective Study on Behalf of the EBMT - Chronic Leukemia Working Party.

Ph. Guardiola, W. Fibbe, T. Ruutu, L. Verdonck, U.W. Schaefer, E. Gluckman, G. Verhoef, J.J. Cornelissen, E. Carreras, N.H. Russel, D. Selleslag, A. Vitek, F. Locatelli, E. Alessandrino, H. Schouten, A. van Biezen, R. Brand, D. Niederwieser, T.M. de Witte

Blood (2004) 104 (11): 1427.

https://doi.org/10.1182/blood.V104.11.1427.1427

Published: 2004

Journal Articles

HLA-Matched Related (MRD) or Unrelated Donor (URD) Non-Myeloablative Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Refractory and Relapsed Aggressive Non Hodgkin Lymphoma (NHL).

L. Norasetthada, M. B. Maris, B. M. Sandmaier, T. Gooley, S. Forman, E. Agura, R. T. Maziarz, J. Shizuru, D. Niederwieser, R. Storb, D. G. Maloney

Blood (2004) 104 (11): 2307.

https://doi.org/10.1182/blood.V104.11.2307.2307

Published: 2004

Journal Articles

Molecular Long-Term Surveillance of CML Patients on Imatinib Therapy. Follow-Up of German Patients Treated within the IRIS Trial.

Martin C. Mueller, MD, P. Paschka, MD, T. Lahaye, MD, Ch. Lorentz, MD, N. Gattermann, MD, D. Niederwieser, MD, G. Ehninger, MD, St Fruehauf, MD, A. Neubauer, MD, Th. Fischer, MD, B. Schultheis, MD, S. Kreil, MD, U. Haus, PhD, R. Hehlmann, MD, A. Hochhaus, MD, the German CML Study Group

Blood (2004) 104 (11): 1003.

https://doi.org/10.1182/blood.V104.11.1003.1003

Published: 2004

Journal Articles

Unrelated Donor Peripheral Blood Stem Cell (PBSC) Transplantation Using Nonmyeloablative Conditioning and Mycophenolate Mofetil (MMF) TID Results in High Engraftment Rates.

Michael B. Maris, MD, B. M. Sandmaier, MD, B. Storer, PhD, J. Shizuru, MD, PhD, D. Maloney, MD, PhD, E. Agura, MD, PhD, D. Niederwieser, MD, M. Pulsipher, MD, R. T. Maziarz, MD, P. McSweeney, MD, J. Wade, MD, A. Langston, MD, T. Chauncey, MD, B. Bruno, MD, A. Woolfrey, MD, M.T. Little, PhD, K. Blume, MD, R. Storb, MD

Blood (2004) 104 (11): 1818.

https://doi.org/10.1182/blood.V104.11.1818.1818

Published: 2004

Journal Articles

HLA-B8 and HLA-A3 Coexpressed With HLA-B8 Are Associated With a Reduced Risk of the Development of Chronic Myeloid Leukemia

E.F.M. Posthuma, J.H.F. Falkenburg, J.F. Apperley, A. Gratwohl, E. Roosnek, B. Hertenstein, R.F. Schipper, G.M.T. Schreuder, J. D’Amaro, M. Oudshoorn, J.H. v Biezen, J. Hermans, R. Willemze, D. Niederwieser

Blood (1999) 93 (11): 3863–3865.

https://doi.org/10.1182/blood.V93.11.3863

Published: 1999

Journal Articles

Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer

B Eibl, H Schwaighofer, D Nachbaur, C Marth, A Gachter, R Knapp, G Bock, C Gassner, L Schiller, F Petersen, D Niederwieser

Blood (1996) 88 (4): 1501–1508.

https://doi.org/10.1182/blood.V88.4.1501.bloodjournal8841501

Published: 1996

Journal Articles

Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3

K Geissler, C Peschel, D Niederwieser, H Strobl, J Goldschmitt, L Ohler, P Bettelheim, P Kahls, C Huber, K Lechner, P Hocker, K Kolbe

Blood (1996) 87 (7): 2732–2739.

https://doi.org/10.1182/blood.V87.7.2732.bloodjournal8772732

Published: 1996

Journal Articles

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]

HJ Kolb, A Schattenberg, JM Goldman, B Hertenstein, N Jacobsen, W Arcese, P Ljungman, A Ferrant, L Verdonck, D Niederwieser

Blood (1995) 86 (5): 2041–2050.

https://doi.org/10.1182/blood.V86.5.2041.bloodjournal8652041

Published: 1995

Journal Articles

Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens

D Niederwieser, A Grassegger, J Aubock, M Herold, D Nachbaur, A Rosenmayr, A Gachter, W Nussbaumer, S Gaggl, M Ritter

Blood (1993) 81 (8): 2200–2208.

https://doi.org/10.1182/blood.V81.8.2200.2200

Published: 1993

Journal Articles

Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies

EU Irschick, F Hladik, D Niederwieser, W Nussbaumer, E Holler, E Kaminski, C Huber

Blood (1992) 79 (6): 1622–1628.

https://doi.org/10.1182/blood.V79.6.1622.1622

Published: 1992

Journal Articles

Human large granular lymphocytes and their relationship to natural killer cell activity in various disease states

G Gastl, D Niederwieser, C Marth, H Huber, D Egg, G Schuler, R Margreiter, H Braunsteiner, C Huber

Blood (1984) 64 (1): 288–295.

https://doi.org/10.1182/blood.V64.1.288.288

Published: 1984

Journal Articles

Prognostic significance of lymphocyte density distribution profiles in adult non-Hodgkin lymphomas

C Huber, D Lutz, D Niederwieser, G Weiser, O Dietze, H Theml, H Braunsteiner

Blood (1982) 60 (6): 1397–1401.

https://doi.org/10.1182/blood.V60.6.1397.1397

Published: 1982

NARROW

Efficacy of Nonmyeloablative Hematopoietic Cell Transplant (HCT) in Secondary Myelodysplastic Syndrome (MDS) and Its Impact on the Primary Disease.

Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes.

Diagnostic Criteria for Hematopoietic Stem Cell Transplantation-Associated Microangiopathy (TAM): Results of a Consensus Process by an International Working Group.

HLA-Matched Related (MRD) or Unrelated Donor (URD) Non-Myeloablative Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Refractory and Relapsed Aggressive Non Hodgkin Lymphoma (NHL).

Molecular Long-Term Surveillance of CML Patients on Imatinib Therapy. Follow-Up of German Patients Treated within the IRIS Trial.

Unrelated Donor Peripheral Blood Stem Cell (PBSC) Transplantation Using Nonmyeloablative Conditioning and Mycophenolate Mofetil (MMF) TID Results in High Engraftment Rates.

HLA-B8 and HLA-A3 Coexpressed With HLA-B8 Are Associated With a Reduced Risk of the Development of Chronic Myeloid Leukemia

Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer

Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]

Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens

Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies

Human large granular lymphocytes and their relationship to natural killer cell activity in various disease states

Prognostic significance of lymphocyte density distribution profiles in adult non-Hodgkin lymphomas

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only